Current challenges and future prospects in oral anticoagulant therapy

J Czuprynska, JP Patel, R Arya - British Journal of …, 2017 - Wiley Online Library
The choice for oral anticoagulant (OAC) therapy was previously limited to the vitamin K
antagonists (VKA s). The advent of the direct oral anticoagulants (DOAC s) brought with it …

Sixteen years of overregulation: time to unburden Mifeprex

Mifeprex REMS Study Group - New England Journal of Medicine, 2017 - Mass Medical Soc
Sixteen Years of Overregulation: Time to Unburden Mifeprex | New England Journal of Medicine
Skip to main content The New England Journal of Medicine homepage Advanced Search …

[HTML][HTML] Anticoagulant treatment for venous thromboembolism: a pooled analysis and additional results of the XALIA and XALIA‐LEA noninterventional studies

S Haas, LG Mantovani, R Kreutz, D Monje… - Research and Practice …, 2021 - Elsevier
Abstract Background The XALIA and XALIA‐LEA prospective, noninterventional studies
investigated the safety and effectiveness of rivaroxaban versus standard anticoagulation for …

A literature review of antithrombotic and anticoagulating agents on sexual function

LWH Chen, HL Yin - Andrologia, 2017 - Wiley Online Library
Although millions of people receive antithrombotic agents (ATA s) or anticoagulating agents
(ACA s) for vascular prophylaxis daily, the negative impact of these agents on sexual …

A novel coagulation parameter monitoring bleeding tendency of Chinese nonvalvular atrial fibrillation patients prescribing dabigatran etexilate

H Wang, Y Zhou, G Rong, L Lu… - Blood Coagulation & …, 2016 - journals.lww.com
The objective of this study was to find a new parameter to monitor bleeding tendency after
dabigatran etexilate (Pradaxa) medication in Chinese nonvalvular atrial fibrillation patients …

[引用][C] Sixteen Years of Overregulation: Time to Unburden Mifeprex

S Board